DOCSLIB.ORG

Small Animal Dermatology

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Small Animal Dermatology Cover Sheet: Request 11400 VEM 5XXX - Small Animal Dermatology Info Process Course|New|Ugrad/Pro Status Pending Submitter Carter,Sharon W [email protected] Created 1/11/2017 3:28:43 PM Updated 2/15/2017 6:19:56 PM Description Small Animal Dermatology (elective) of request Actions Step Status Group User Comment Updated Department Approved VM - Small MILNER, 1/11/2017 Animal Clinical ROWAN JAMES Sciences 312809000 Added R1.CVM_syllabus_SA Dermatology.pdf 1/11/2017 Added notes.elective2016.withschedule.pdf 1/11/2017 College Approved VM - College of Thomas 1/12/2017 Veterinary Vickroy Medicine No document changes University Comment PV - University Case, Brandon Added to the February 1/23/2017 Curriculum Curriculum agenda. Committee Committee (UCC) No document changes University Pending PV - University 1/23/2017 Curriculum Curriculum Committee Committee (UCC) No document changes Statewide Course Numbering System No document changes Office of the Registrar No document changes Student Academic Support System No document changes Catalog No document changes College Notified No document changes Course|New for request 11400 Info Request: VEM 5XXX - Small Animal Dermatology Description of request: Small Animal Dermatology (elective) Submitter: Carter,Sharon W [email protected] Created: 2/1/2017 9:06:14 AM Form version: 2 Responses Recommended PrefixVEM Course Level 5 Number XXX Category of Instruction Advanced Lab Code None Course TitleSmall Animal Dermatology Transcript TitleSA Dermatology Degree TypeProfessional Delivery Method(s)On-Campus Co-ListingNo Effective Term Fall Effective Year2017 Rotating Topic?No Repeatable Credit?No Amount of Credit2 If variable, # min 0 If variable, # max0 S/U Only?No Contact Type Regularly Scheduled Weekly Contact Hours 2 Course Description The goals: are to provide advanced knowledge on how to logically and systematically approach small animal dermatological diseases with particular emphasis on problem based approach. This course will include information regarding the clinical presentations, diagnostic approach and treatment of allergic, infectious, autoimmune and immune-mediated skin diseases of small animals. Prerequisites Only students with the major code VM Co-requisites No Rationale and Placement in Curriculum Offered in Fall for 4th year students in advanced didactic courses. Course Objectives The specific objectives are for the students to become familiar with a problem based approach and learn how to approach cases in a logical step-by-step manner both in terms of diagnosis and management. Additional objectives are to provide the students with knowledge on the pathogenesis and clinical signs of skin diseases of dogs and cats that are encountered in clinical practice and were not addressed in the core dermatology course (VEM 5387). Besides providing lectures, this course also provide opportunities for case discussion in which 3 instructors (Drs. Santoro, Gram and Marsella) will encourage students to participate in discussing clinical cases. This approach has the aim to encourage application of knowledge and open discussion of the pros and cons of different approaches that could be taken on various clinical cases. There will be no laboratory time in this course. By the end of the coursework, the student will be able to explain the necessary types of diagnostic tests and the reasons for performing them when evaluating your patients. The student will be able to discuss pros and cons of different therapy approaches for various diseases and customize the recommendations to individual cases. Course Textbook(s) and/or Other Assigned ReadingSCAVMA notes provided by Dr. Marsella Recommended/ Reference texts British Small Animal Veterinary Association manual of Dermatology of dogs and Cats, 3rd Edition. Additional Resources/ equipment: SCAVMA notes provided for the sophomore core dermatology course Weekly Schedule of Topics 1. Introduction to Problem Based Dermatology 2. Diagnostic approach to Pruritus 3. Management of Pruritus…………… 4. Steroid therapy 5. Approach to Macular/Papular Pustular/Dermatoses 6. Approach to Crusting Scaling Dermatoses 7. Approach to nodular dermatitis 8. Approach to Alopecia (focal/multifocal) 9. Approach to Alopecia (symmetric) 10. Endocrine Interpretation / Tests… 11. Approach to Erosive Ulcerative Dermatoses 12. Approach to Pigmentary Abnormalities 13. Regional Dermatoses 1 (perineal, pinnae, claws) 14. Regional Dermatoses 2 (nose, footpad) 14. Approach to otitis 15. Antimicrobial Resistance 17. Discussion of clinical cases 18. Discussion of clinical cases 19. Discussion of clinical cases 20. Discussion of clinical cases 21. Discussion of clinical cases 22. Discussion of clinical cases 23. Discussion of clinical cases 24. Discussion of clinical cases 25. Discussion of clinical cases 26. Discussion of clinical cases 28. Discussion of clinical cases 29. Review 30. Review Links and PoliciesFor more information, please refer to: https://catalog.ufl.edu/ugrad/current/regulations/info/grades.aspx. The student’s grades will be posted on the course’s E-Learning site. The students will be notified as soon as the grades become available. There will be no practical assessment of clinical skills Class Attendance and Make-Up Policy Class attendance is strongly encouraged. Excused absences are consistent with university policies in the undergraduate catalog (https://catalog.ufl.edu/ugrad/current/regulations/info/attendance.aspx) and require appropriate documentation. A makeup final exam will be provided for students who miss either exam due to extreme, documented circumstances. Students should arrange with the instructor for makeup material. Students Requiring Accommodations Students with disabilities requesting accommodations should first register with the Disability Resource Center (352-392-8565, www.dso.ufl.edu/drc/) by providing appropriate documentation. Once registered, students will receive an accommodation letter which must be presented to the instructor when requesting accommodation. Students with disabilities should follow this procedure as early as possible in the semester. Course Evaluation Students are expected to provide feedback on the quality of instruction in this course by completing online evaluations at https://evaluations.ufl.edu. Evaluations are typically open during the last two or three weeks of the semester, but students will be given specific times when they are open. Summary results of these assessments are available to students at https://evaluations.ufl.edu/results/. Class Demeanor Students are expected to arrive to class on time and behave in a manner that is respectful to the instructor and to fellow students. University Honesty Policy UF students are bound by The Honor Pledge which states, “We, the members of the University of Florida community, pledge to hold ourselves and our peers to the highest standards of honor and integrity by abiding by the Honor Code. On all work submitted for credit by students at the University of Florida, the following pledge is either required or implied: “On my honor, I have neither given nor received unauthorized aid in doing this assignment.” The Honor Code (https://www.dso.ufl.edu/sccr/process/student-conduct- honor-code/) specifies a number of behaviors that are in violation of this code and the possible sanctions. Furthermore, you are obligated to report any condition that facilitates academic misconduct to appropriate personnel. If you have any questions or concerns, please consult with the instructor Counseling and Wellness Center Contact information for the Counseling and Wellness Center: http://www.counseling.ufl.edu/cwc/Default.aspx, 392-1575; and the University Police Department: 392-1111 or 9-1-1 for emergencies. Grading Scheme The final grades assigned for this course will be based on the percentage of total points earned. The UF grading scheme will be used for this course. Percent Grade Grade Points 93.4-100 A 4.00 90.0-93.3 A- 3.67 86.7-89.9 B+ 3.33 83.4-86.6 B 3.00 80.0-83.3 B- 2.67 76.7-79.9 C+ 2.33 73.4-76.6 C 2.00 70.0-73.3 C- 1.67 66.7-69.9 D+ 1.33 63.4-66.6 D 1.00 60.0-63.3 D- 0.67 0-59.9 E 0.00 Instructor(s) Dr. Rosanna Marsella (Courses Coordinator) Dr. Dunbar Gram Dr. Domenico Santoro Small animal dermatology - elective course 2016 Course Coordinator: Dr. Rosanna Marsella Participants: Drs. Dunbar Gram, Rosanna Marsella, and Domenico Santoro Topic Instructor Date Day and time Page 1. Introduction to problem Marsella 8.23.16 Tue 10:30-11:30 3 based dermatology 2. Approach to Marsella 8.23.16 Tue 11:30-12:20 17 macular/papular/pustular dermatoses 3. Approach to Marsella 8.24.16 Wed 10:30-11:30 34 focal/multifocal alopecia 4. Approach to nodular Marsella 8.24.16 Wed 11:30-12:20 55 dermatoses 5. Diagnostic approach to Gram 8.30.16 Tue 10:30-11:30 75 pruritus (Endocrine diseases) 6. Management of pruritus Santoro 8.30.16 Tue 11:30-12:20 89 7. Steroid therapy Gram 8.31.16 Wed 10:30-11:30 94 8. Approach to symmetric Gram 8.31.16 Wed 11:30-12:20 103 alopecia 9. Regional dermatoses Santoro 9.6.16 Tue 10:30-11:30 122 (perineal, pinnae, claws) 10. Regional dermatoses Santoro 9.6.16 Tue 11:30-12:20 126 (nose, footpads) 11. Approach to otitis Santoro 9.7.16 Wed 10:30-11:30 129 12. Antimicrobial resistance Santoro 9.7.16 Wed 11:30-12:20 132 13. Endocrine tests Gram 9.8.16 Thu 10:30-11:30 See endocrine interpretation lecture -75 14. Approach to crusting and Santoro 9.8.16 Thu 11:30-12:20 136 scaling dermatoses 1 15. Approach to Marsella 9.9.16 Fri 10:30-11:30 141 erosive/ulcerative dermatoses 16. Approach to pigmentary Marsella 9.9.16 Fri 11:30-12:20 158 abnormalities 17. Clinical cases All 3 9.12.16 Mon 8:30-9:20 18. Discussion All 3 9.12.16 Mon 9:30-10:20 19. Clinical cases All 3 9.13.16 Tue 10:30-11:30 20.
Load more

Recommended publications
  • Primary Follicular Mucinosis
    International Journal of Scientific & Engineering Research Volume 8, Issue 6, June-2017 1303 ISSN 2229-5518 Case Report Primary Follicular Mucinosis: A Case Report From Saudi Arabia With Successful Treatment And Literature Review SalaimanAlsaiari1 AwadhAlAmri2 AmerAlmuqati Ibrahim Allihibi ABSTRACT: Background:Follicular mucinosis is an uncommon inflammatory disorder that characteristically presents as clearly defined, erythematous plaques or papules, with follicular projections, superficial scaling, and alopecia in terminal hair bearing areas, characterized histologically by mucin accumulation in pilosebaceous units (follicular epithelium and sebaceous glands) . The condition is generally divided into primary (idiopathic) and secondary forms in association with several conditions including benign and malignant diseases. There are many local and systemic treatments. Main observations: We report a case of 15 years old male with primary follicular mucinosis treated effectively by intralesional steroid injections. Conclusions: This is a new case of Primary follicular mucinosis from Saudi Arabia was treated successfully with intralesional corticosteroids without relapse. KEYWORDS:follicular mucinosis, intralesional corticosteroids, treatment. —————————— —————————— INTRODUCTIONIJSER Follicular mucinosis is a rare condition, of unknown cause, which affects all races, ages and both sexes.1,2It is defined as the accumulation of mucin in the follicular epithelium and sebaceous glands.3,5 It was initially described in 1957 by Pinkus who named it
    [Show full text]
  • Dermatology Volume 58 Issue 2 March-April 2013 Indian Journal Of
    Indian Journal of ISSN: 0019-5154 Dermatology Volume 58 Issue 2 March-April 2013 Indian Journal of Highlights of the issue Dermatology • Update on cutaneous calciphylaxis • Macrophage migration inhibitory factor in • V Dermatology olume • Fixed duration therapy in leprosy 58 • Issue • Environmental dermatoses in Ladakh • Demodex folliculorum as a risk factor in 2 • Diagnosing rosacea March-April • Annular lesions in Dermatology 2013 • Pages Clinical and photomicrograph of Mycosis fungoides, PET-CT for staging and response assessment IJD® Symposium: Integrative Dermatology 87-**** Guest Editor: S R Narahari IJD® www.e-ijd.org E‑Case Report Angiolymphoid Hyperplasia with Eosinophilia with Follicular Mucinosis Rameshwar Gutte, Bhavana Doshi, Uday Khopkar From the Department of Dermatology, Seth G. S. Medical College and King Edward Memorial Hospital, Mumbai, India Abstract Follicular mucinosis occurring along with angiolymphoid hyperplasia with eosinophils (ALHE) has been described in a 49-year-old male. The patient presented with pruritic hyperpigmented papules and nodules on the vertex and right parietal scalp. There was no any other complaint. Histopathological examination from one of the papule showed prominent blood vessels in the dermis lined by plump histiocytoid endothelial cells that were surrounded by a dense lymphoid infiltrate with numerous eosinophils; these findings are typical of angiolymphoid hyperplasia with eosinophilia. Features of follicular mucinosis were observed in the same section with 3 hyperplastic follicular infundibula containing pools of mucin in the infundibular epithelium. The concurrent occurrence of these 2 distinct histopathological patterns in the same biopsy specimen has been reported rarely. Key Words: Angiolymphoid hyperplasia, eosinophilia, follicular mucinosis, scalp What was known? perivascular area and other parts of the dermis.
    [Show full text]
  • Alopecia, Particularly:  Alopecia Areata  Androgenetic Alopecia  Telogen Effluvium  Anagen Effluvium
    432 Teams Dermatology Hair disorders Color Code: Original, Team’s note, Important, Doctor’s note, Not important, Old teamwork Done by: Shaikha Aldossari Reviewer: Lama AlTawil 8 Team Leader: Basil Al Suwaine&Lama Al Tawil 432 Dermatology Team Lecture 8: Hair Disorders Objectives 1- Normal anatomy of hair follicle and hair cycle. 2- Causes, features and management of non scarring alopecia, particularly: Alopecia areata Androgenetic alopecia Telogen effluvium Anagen effluvium 3- Causes and features of scarring alopecia. 4- Causes and features of Excessive hair growth. hair disorder Excessive hair Alopecia growth non scarring Hirsutism Hypertrichosis scarring Anagen Telogen Androgenetic Alopecia effluvium effluvium Alopecia Areata P a g e | 1 432 Dermatology Team Lecture 8: Hair Disorders Anatomy of hair follicle: The Arrector piliResponsible for piloerection (goose bumps ) that happens when one is cold (produces energy and therefor warmth) . hair follicle becomes vertical instead of oblique Cuticle is the last layer here . what we can see outside . it has 7 layers of keratinocytes How many hairs in the body? 5 millions hairs in the body, 100,000 in the scalp. Growth rate: 0.3mm/day for scalp hair i.e.1cm/month Hair follicle bulge: -Very important part since it has stem cells .its the inertion of the arrector pili Hair follicle on vertical section: -So any pathological process affecting any part other Initially the shaft and the follicle are one than this, hair would still be able to regrow. organ then when you reach 1/3 the follicle -If we want to destroy a hair follicle, we’d target the bulge.
    [Show full text]
  • Eosinophils in Skin Diseases
    Seminars in Immunopathology (2021) 43:393–409 https://doi.org/10.1007/s00281-021-00868-7 REVIEW Eosinophils in skin diseases Susanne Radonjic-Hoesli1 & Marie-Charlotte Brüggen2,3,4 & Laurence Feldmeyer1 & Hans-Uwe Simon5,6,7 & Dagmar Simon1 Received: 27 April 2021 /Accepted: 6 May 2021 / Published online: 7 June 2021 # The Author(s) 2021 Abstract Eosinophil infiltration is a common finding in a broad spectrum of skin diseases, despite the fact that the skin is devoid of eosinophils under physiologic conditions. Although cutaneous eosinophilia is reactive, cytokine-mediated in most cases, diseases with an intrinsic mutation-mediated clonal expansion of eosinophils can also manifest on the skin. As eosinophils are involved in host defense, regulate immune responses, generate pruritus, induce remodeling and fibrosis, and can cause tissue damage, they have the capacity to actively contribute to the pathogenesis of diseases. Recent research provided deeper insights in the mech- anisms, e.g., bacterial and viral clearance, blister formation, recruitment of cytotoxic T cells, and generation of pruritus, by which eosinophils might come into action. This review aims at providing an overview on the clinical presentations of eosinophil- associated dermatoses and the current understanding of their pathogenic role in these diseases. Further, we discuss the effects of therapies targeting eosinophils. Keywords Eosinophil . Granule proteins . Host defense . Immunoregulation . Tissue damage Introduction fact that the skin does not harbor eosinophils under physio- logic conditions. As eosinophilic dermatoses lack any spe- Eosinophil infiltration of the skin is a frequent histopatho- cific clinical sign or pattern, a skin biopsy and histology logical finding in a broad spectrum of dermatological disor- together with the clinical manifestations are often required ders.
    [Show full text]
  • University of Chicago, December 2014
    Chicago Dermatological Society December 2014 Monthly Educational Conference Program Information Continuing Medical Education Certification and Case Presentations Wednesday, December 3, 2014 Gleacher Conference Center Conference Host: Section of Dermatology University of Chicago Hospitals Chicago, Illinois Program Conference Location Gleacher Conference Center 450 N. Cityfront Plaza Dr., Chicago All meeting activities take place on the 6th Floor of the Gleacher Center. 8:30 a.m. Registration & Continental Breakfast with the exhibitors 6th Floor Lobby 9:00 a.m. - 10:00 a.m. University of Chicago Medenica Lecture - Room 621 "Cutaneous Infections in Non-immunocompromised Hosts" Wayne Grayson, MBChB, PhD, FCPath 9:30 a.m. - 10:45 a.m. Clinical Rounds Patient Viewing - Rooms 600 & 602 Posters - North Foyer Slide Viewing - Room 608 11:00 a.m. - 12:00 p.m. General Session - Room 621 LORINCZ LECTURE "Dermatopathology of HIV/AIDS: Lessons Learned" Wayne Grayson, MBChB, PhD, FCPath 12:00 p.m. - 12:30 p.m. Box Lunches & visit with exhibitors 6th Floor 12:30 p.m. - 12:45 p.m. CDS Business meeting – Room 621 12:45 p.m. - 2:30 p.m. Case Discussions – Room 621 2:30 p.m. - 2:45 p.m. MOC Self-Assessment Questions – Room 621 2:45 p.m. Meeting adjourns Mark the Date! Next CDS monthly meeting... President’s Conference and Annual Awards Luncheon Wednesday, February 25, 2015 at the Stephens Convention Center in Rosemont Illinois Dermatological Society Practice Management & Coding Workshop Saturday, January 31, 2015; Stephens Convention Center in Rosemont Watch for details on the CDS website: www.ChicagoDerm.org Save time and consider registering online! Guest Speaker Delivering the Allen Lorincz Memorial Lecture and the University of Chicago Medenica Lecture WAYNE GRAYSON MBCHB, PHD Honorary Professor of Pathology; University of Witwatersrand; Johannesburg, South Africa Dr.
    [Show full text]
  • Wells' Syndrome Proceeded by Leukocytoclastic Vasculitis
    Wells’ Syndrome Proceeded by Leukocytoclastic Vasculitis: A Discussion with New Insights into Analogous Pathophysiology S. Brandon Nickle, DO,* Roxanne Rajaii, MS, DO,** Zachary Hopkins, BS,*** Nelson Charlie, MD**** *Dermatology Resident , 4th year, Broward Health Medical Center, Ft. Lauderdale, FL **Dermatology Resident, 2nd year, Beaumont Hospital, Farmington Hills, MI ***Medical Student, 4th year, University of Utah School of Medicine, Salt Lake City, UT ****Attending Dermatologist, Lauderdale Academic Dermatology at Broward Medical Center, Ft. Lauderdale, FL Disclosures: None Correspondence: Brandon Nickle, DO; 4331 SW 78th Dr., Davie, FL 33328; Fax: 801-318-1431; [email protected] Abstract Wells’ syndrome, also referred to as eosinophilic cellulitis, is a rare inflammatory dermatosis. Although its etiology is unknown, it is thought to be an abnormal eosinophilic response to one of various causative agents. Its cutaneous manifestations vary in morphology and severity, but the disease often follows a relapsing-remitting course. We report the case of a patient with Wells’ syndrome preceded by leukocytoclastic vasculitis (LCV). Introduction bulla on the left lateral leg, and one perilesional syndrome. The patient was given a one-month Wells’ syndrome, also referred to as eosinophilic biopsy from skin directly adjacent to the bulla. course of prednisone and was free of symptoms cellulitis, is an uncommon inflammatory They were sent for direct immunofluorescence at three-month follow-up. She was lost to dermatosis, with fewer than 200 cases reported (DIF), which revealed an overwhelming number further follow-up. worldwide.2 It was first described in 1971 by of eosinophils in the superficial and deep dermis George Wells, noted as a rare entity with an (Figures 5, 6 [p.
    [Show full text]
  • Differential Diagnosis of the Scalp Hair Folliculitis
    Acta Clin Croat 2011; 50:395-402 Review DIFFERENTIAL DIAGNOSIS OF THE SCALP HAIR FOLLICULITIS Liborija Lugović-Mihić1, Freja Barišić2, Vedrana Bulat1, Marija Buljan1, Mirna Šitum1, Lada Bradić1 and Josip Mihić3 1University Department of Dermatovenereology, 2University Department of Ophthalmology, Sestre milosrdnice University Hospital Center, Zagreb; 3Department of Neurosurgery, Dr Josip Benčević General Hospital, Slavonski Brod, Croatia SUMMARY – Scalp hair folliculitis is a relatively common condition in dermatological practice and a major diagnostic and therapeutic challenge due to the lack of exact guidelines. Generally, inflammatory diseases of the pilosebaceous follicle of the scalp most often manifest as folliculitis. There are numerous infective agents that may cause folliculitis, including bacteria, viruses and fungi, as well as many noninfective causes. Several noninfectious diseases may present as scalp hair folli- culitis, such as folliculitis decalvans capillitii, perifolliculitis capitis abscendens et suffodiens, erosive pustular dermatitis, lichen planopilaris, eosinophilic pustular folliculitis, etc. The classification of folliculitis is both confusing and controversial. There are many different forms of folliculitis and se- veral classifications. According to the considerable variability of histologic findings, there are three groups of folliculitis: infectious folliculitis, noninfectious folliculitis and perifolliculitis. The diagno- sis of folliculitis occasionally requires histologic confirmation and cannot be based
    [Show full text]
  • A Deep Learning System for Differential Diagnosis of Skin Diseases
    A deep learning system for differential diagnosis of skin diseases 1 1 1 1 1 1,2 † Yuan Liu ,​ Ayush Jain ,​ Clara Eng ,​ David H. Way ,​ Kang Lee ,​ Peggy Bui ,​ Kimberly Kanada ,​ ​ ​ ‡ ​ 1​ ​ 1 ​ 1 ​ Guilherme de Oliveira Marinho ,​ Jessica Gallegos ,​ Sara Gabriele ,​ Vishakha Gupta ,​ Nalini 1,3,§ 1 ​ ​ 4 ​ 1 ​ ​ 1 Singh ,​ Vivek Natarajan ,​ Rainer Hofmann-Wellenhof ,​ Greg S. Corrado ,​ Lily H. Peng ,​ Dale ​ ​ 1 1 ​ † 1, ​ 1, ​ 1, ​ R. Webster ,​ Dennis Ai ,​ Susan Huang ,​ Yun Liu *​ , R. Carter Dunn *​ *, David Coz *​ * ​ ​ ​ ​ ​ ​ Affiliations: 1 G​ oogle Health, Palo Alto, CA, USA 2 U​ niversity of California, San Francisco, CA, USA 3 M​ assachusetts Institute of Technology, Cambridge, MA, USA 4 M​ edical University of Graz, Graz, Austria † W​ ork done at Google Health via Advanced Clinical. ‡ W​ ork done at Google Health via Adecco Staffing. § W​ ork done at Google Health. *Corresponding author: [email protected] **These authors contributed equally to this work. Abstract Skin and subcutaneous conditions affect an estimated 1.9 billion people at any given time and remain the fourth leading cause of non-fatal disease burden worldwide. Access to dermatology care is limited due to a shortage of dermatologists, causing long wait times and leading patients to seek dermatologic care from general practitioners. However, the diagnostic accuracy of general practitioners has been reported to be only 0.24-0.70 (compared to 0.77-0.96 for dermatologists), resulting in over- and ​ ​ ​ ​ ​ ​ ​ under-referrals, delays in care, and errors in diagnosis and treatment. In this paper, we developed a deep learning system (DLS) to provide a differential diagnosis of skin conditions for clinical cases (skin photographs and associated medical histories).
    [Show full text]
  • Global Development Assistance for Adolescent Health from 2003 to 2015
    Supplementary Online Content Li Z, Li M, Patton GC, Lu C. Global development assistance for adolescent health from 2003 to 2015. JAMA Netw Open. 2018;1(4):e181072. doi:10.1001/jamanetworkopen.2018.1072 eTable 1. List of Donor Countries Included in the CRS eTable 2. 132 Recipients in the CRS (According to the World Health Organization Regions) eTable 3. Key Words to Identify the Related Age Group (Adolescence) in the Creditor Reporting System eTable 4. CRS Purpose Name and Respective Fractions Allocated to Adolescent Health eTable 5. Definitions of DAAH on the Leading Causes of DALYs of Adolescent Health eTable 6. Key Words Used to Search for Projects on Skin and Subcutaneous Diseases in the Creditor Reporting System eTable 7. Key Words Used to Search for Road Injury Projects in the Creditor Reporting System eTable 8. Key Words Used to Search for HIV/AIDS Projects in the Creditor Reporting System eTable 9. Key Words Used to Search for Projects on Iron-Deficiency Anemia in the Creditor Reporting System eTable 10. Key Words Used to Search for Self-Harm Projects in the Creditor Reporting System eTable 11. Key Words Used to Search for Projects on Interpersonal Violence in the Creditor Reporting System eTable 12. Key Words Used to Search for Projects on Depressive Disorders in the Creditor Reporting System eTable 13. Key Words Used to Search for Projects on Lower Back and Neck Pain in the Creditor Reporting System eTable 14. Key Words Used to Search for Diarrheal Projects in the Creditor Reporting System eTable 15. Key Words Used to Search for Tuberculosis Projects in the Creditor Reporting System eTable 16.
    [Show full text]
  • (12) United States Patent (10) Patent No.: US 7,359,748 B1 Drugge (45) Date of Patent: Apr
    USOO7359748B1 (12) United States Patent (10) Patent No.: US 7,359,748 B1 Drugge (45) Date of Patent: Apr. 15, 2008 (54) APPARATUS FOR TOTAL IMMERSION 6,339,216 B1* 1/2002 Wake ..................... 250,214. A PHOTOGRAPHY 6,397,091 B2 * 5/2002 Diab et al. .................. 600,323 6,556,858 B1 * 4/2003 Zeman ............. ... 600,473 (76) Inventor: Rhett Drugge, 50 Glenbrook Rd., Suite 6,597,941 B2. T/2003 Fontenot et al. ............ 600/473 1C, Stamford, NH (US) 06902-2914 7,092,014 B1 8/2006 Li et al. .................. 348.218.1 (*) Notice: Subject to any disclaimer, the term of this k cited. by examiner patent is extended or adjusted under 35 Primary Examiner Daniel Robinson U.S.C. 154(b) by 802 days. (74) Attorney, Agent, or Firm—McCarter & English, LLP (21) Appl. No.: 09/625,712 (57) ABSTRACT (22) Filed: Jul. 26, 2000 Total Immersion Photography (TIP) is disclosed, preferably for the use of screening for various medical and cosmetic (51) Int. Cl. conditions. TIP, in a preferred embodiment, comprises an A6 IB 6/00 (2006.01) enclosed structure that may be sized in accordance with an (52) U.S. Cl. ....................................... 600/476; 600/477 entire person, or individual body parts. Disposed therein are (58) Field of Classification Search ................ 600/476, a plurality of imaging means which may gather a variety of 600/162,407, 477, 478,479, 480; A61 B 6/00 information, e.g., chemical, light, temperature, etc. In a See application file for complete search history. preferred embodiment, a computer and plurality of USB (56) References Cited hubs are used to remotely operate and control digital cam eras.
    [Show full text]
  • NOVEMBER 15, 2006 University of Chicago (Map Attached) Enter
    Wednesday - NOVEMBER 15, 2006 University of Chicago (Map attached) • Plans & Policy Committee Meeting: M - 137 / Lectures: Frank Billings Auditorium P- 117 Enter through Wyler Children’s Hospital (the old Children’s Hospital) at 5841 S. Maryland Ave., Chicago, IL • Patient and slide viewing – (DCAM) Duchossois Center for Advanced Medicine: 5758 S. Maryland Ave., Chicago, IL **Parking spaces in the main parking garage are limited. Valet parking is highly recommended. Please see maps for details.** 8:00 a.m. – 10:00 a.m. Room M-137 Plans & Policy Committee Meeting Enter thru Wyler Children’s Hospital main entrance 5841 S. Maryland 9:00 a.m. – 11:00 a.m. P-117 Registration Frank Billings Auditorium Derm Clinic DCAM 6C will also have attendance Enter thru Wyler Children’s Hospital main entrance check in, badge pick-up at P-117 auditorium 5841 S. Maryland 9:00 a.m. – 10:00 a.m. P-117 Resident Lecture – Dr. Thomas N. Darling (Frank Billings Auditorium) 9:30 a.m. – 11:00 a.m. DCAM 6C Patient Viewing Duchossois Center for Advanced Medicine 5758 S. Maryland Ave. 9:30 a.m. – 11:00 a.m. DCAM 1402 Slide Viewing 5758 S. Maryland Ave. 11:00 a.m. – 11:15 a.m. P-117 CDS Business Meeting (Frank Billings Auditorium) 11:15 a.m. – 12:00 p.m. P-117 Guest Lecture – Dr. Thomas N. Darling (Frank Billings Auditorium) 12:00 a.m. – 12:30 p.m. P-117 Lunch (Frank Billings Auditorium) 12:30 p.m. – 2:00 p.m. P-117 Case discussions (Frank Billings Auditorium) Allan Lorincz Lecture Guest Speaker Thomas N.
    [Show full text]
  • Dermatopathology: We've Only Just
    Paul K. Shitabata, M.D. Dermatopathology Institute Pa#erns Epidermis Dermis/Vessels/Hair Follicles Fat/Vessels Epidermal Reac1on Pa#erns Orthokeratosis Hyperkeratosis Spongiosis Modify by Inflammatory Cell type Parakeratosis Acanthosis Spongiosis Parakeratosis Acanthosis Hyperkeratosis Orthokeratosis Hyperkeratosis Acanthosis Epidermal/Dermal Reac1on Pa#erns Superficial perivascular Superficial and deep perivascular Nodular and diffuse Intraepidermal vesicular and pustular Subepidermal vesicular No Epidermal Changes Perivascular Intestitial Superficial/Deep Epidermal Changes Spongiotic Epidermal Changes Ballooning Interface Psoriasiform/Lichenoid Lichenoid/Interface Spongiotic Psoriasiform Psoriasiform Lichenoid Superficial Perivascular No Epidermal Changes Tinea versicolor Dermatophytosis Erythrasma Pitted keratolysis Vitiligo Schamberg's disease Viral exanthems Drug eruption (one type) Urticaria, late Erythema figuratum, superficial Superficial Perivascular/Inters11al No Epidermal Changes Schamberg's disease PUPPP Dermatitis herpetiformis Linear IgA dermatosis Dermatitis herpetiformis-like drug eruptions Acute discoid lupus erythematosus/SLE Leukocytoclastic vasculitis Erythema marginatum Superficial Perivascular/Inters11al No Epidermal Changes Bullous pemphigoid/Herpes gestationis, urticarial Pemphigus vulgaris, urticarial Arthropod PUPPP Urticaria Postinflammatory pigmentary alteration Macular amyloidosis Urticaria pigmentosa Brachioradial pruritis Superficial Perivascular Psoriasiform Psoriasis Allergic contact dermatitis Nummular
    [Show full text]